16,655 Shares in Surgery Partners, Inc. (NASDAQ:SGRY) Bought by Wesbanco Bank Inc.

Posted by on Mar 28th, 2023

Wesbanco Bank Inc. bought a new position in Surgery Partners, Inc. (NASDAQ:SGRY – Get Rating) during the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 16,655 shares of the company’s stock, valued at approximately $464,000.

A number of other institutional investors also recently bought and sold shares of SGRY. FMR LLC raised its holdings in Surgery Partners by 13.5% in the 2nd quarter. FMR LLC now owns 13,484,523 shares of the company’s stock worth $389,972,000 after purchasing an additional 1,606,776 shares during the period. Point72 Asset Management L.P. raised its holdings in Surgery Partners by 381.4% in the 2nd quarter. Point72 Asset Management L.P. now owns 985,912 shares of the company’s stock worth $28,513,000 after purchasing an additional 781,126 shares during the period. Cannell & Co. raised its holdings in Surgery Partners by 147.0% in the 3rd quarter. Cannell & Co. now owns 892,155 shares of the company’s stock worth $20,876,000 after purchasing an additional 530,910 shares during the period. Durable Capital Partners LP raised its holdings in Surgery Partners by 26.0% in the 3rd quarter. Durable Capital Partners LP now owns 2,134,229 shares of the company’s stock worth $49,941,000 after purchasing an additional 439,949 shares during the period. Finally, Marshall Wace LLP bought a new position in Surgery Partners in the 3rd quarter worth $8,783,000.

Insider Buying and Selling

In related news, insider Bradley R. Owens sold 1,669 shares of Surgery Partners stock in a transaction dated Monday, March 13th. The stock was sold at an average price of $30.10, for a total value of $50,236.90. Following the completion of the transaction, the insider now owns 83,959 shares in the company, valued at $2,527,165.90. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, insider Bradley R. Owens sold 1,669 shares of Surgery Partners stock in a transaction dated Monday, March 13th. The stock was sold at an average price of $30.10, for a total value of $50,236.90. Following the completion of the transaction, the insider now owns 83,959 shares in the company, valued at $2,527,165.90. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Jason Eric Evans sold 10,300 shares of Surgery Partners stock in a transaction dated Monday, March 13th. The stock was sold at an average price of $30.11, for a total value of $310,133.00. Following the completion of the transaction, the chief executive officer now owns 426,554 shares of the company’s stock, valued at approximately $12,843,540.94. The disclosure for this sale can be found here. Over the last quarter, insiders sold 72,624 shares of company stock worth $2,410,750. Corporate insiders own 3.30% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on SGRY. StockNews.com initiated coverage on Surgery Partners in a report on Thursday, March 16th. They issued a “sell” rating on the stock. JPMorgan Chase & Co. decreased their price target on Surgery Partners from $45.00 to $40.00 and set a “neutral” rating on the stock in a report on Thursday, March 2nd. Benchmark reissued a “buy” rating and set a $47.00 price target on shares of Surgery Partners in a report on Monday, March 6th. Citigroup raised their price target on Surgery Partners from $38.00 to $40.00 in a report on Thursday, March 2nd. Finally, Barclays decreased their price target on Surgery Partners from $69.00 to $56.00 and set an “overweight” rating on the stock in a report on Wednesday, January 18th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and five have given a buy rating to the company. According to MarketBeat, Surgery Partners presently has a consensus rating of “Moderate Buy” and a consensus price target of $42.00.

Surgery Partners Price Performance

Shares of SGRY stock opened at $31.90 on Tuesday. Surgery Partners, Inc. has a 12-month low of $20.46 and a 12-month high of $63.87. The company has a quick ratio of 1.72, a current ratio of 1.87 and a debt-to-equity ratio of 0.87. The stock’s 50-day moving average price is $33.13 and its 200-day moving average price is $29.07.

Surgery Partners (NASDAQ:SGRY – Get Rating) last issued its earnings results on Wednesday, March 1st. The company reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.16 by $0.06. Surgery Partners had a negative return on equity of 0.14% and a negative net margin of 2.15%. The firm had revenue of $707.10 million for the quarter, compared to analysts’ expectations of $688.34 million. Analysts expect that Surgery Partners, Inc. will post 0.4 earnings per share for the current year.

Surgery Partners Company Profile

(Get Rating)

Surgery Partners, Inc is healthcare services holding company, which engages in the provision of solutions for surgical and related ancillary care in support of its patients and physicians. It operates through the following business segments: Surgical Facility Services, Ancillary Services, and Optical Services.

Featured Articles

Want to see what other hedge funds are holding SGRY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Surgery Partners, Inc. (NASDAQ:SGRY – Get Rating).

Institutional Ownership by Quarter for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.